Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- Prescribing: Opioid(s)
- 3.00 AMA PRA Category 1 Credit™
- 3.00 ANCC
$18.00
Opioid analgesic medications can bring substantial relief to patients suffering from pain. However, the inappropriate use, abuse, and diversion of prescription drugs in America, particularly prescription opioids, has increased dramatically in recent years and has been identified as a national public health epidemic. A set of clinical tools, guidelines, and recommendations are now available for prescribers who treat pain patients with opioids.
- Prescribing: Opioid(s)
- Risk Management
- Pharmacology
- 15.00 AMA PRA Category 1 Credit™
- 15.00 ANCC
$105.00
This course will extensively cover the various approaches recommended or mandated for use by clinicians who prescribe opioids, in order to reduce risk and improve outcomes. The goal of this course is provide clinicians with an understanding of the essential components of appropriate opioid prescribing.
- Prescribing: Opioid(s)
- 2.00 AAFP Prescribed
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC
$0.00
SCOPE of Pain is a series of continuing medical education/continuing nursing education activities designed to help you safely and effectively manage patients with acute and/or chronic pain, when appropriate, with opioid analgesics. Our program consists of a free 2-module, case-based online activity and live conferences held around the US. Through the case of Michelle Jones, a 36-year-old who has a displaced right femoral neck fracture due to a motor vehicle crash, you'll learn how to:
- Prescribing: Opioid(s)
- Pharmacology
- 3.00 AMA PRA Category 1 Credit™
- 3.00 ANCC
$21.00
Opioid analgesic medications can bring substantial relief to patients suffering from pain. However, the inappropriate use, abuse, and diversion of prescription drugs in America, particularly prescription opioids, has increased dramatically in recent years and has been identified as a national public health epidemic. A set of clinical tools, guidelines, and recommendations are now available for prescribers who treat pain patients with opioids.
- Prescribing: Opioid(s)
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC
$30.00
This on-demand course provides an overview for Iowa clinicians of the CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. It is jointly provided by Iowa Medical Society.Iowa Licensure Requirement: The course fulfills Iowa's requirement for clinicians who prescribe opioids (Nurse Practitioners, Physician Assistants/Associates, Physicians) to complete 2 hours of continuing education regarding the CDC Clinical Practice Guideline for Prescribing Opioids for Pain.
- Prescribing: Opioid(s)
- Pain Management: Opioid(s)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
$0.00
This module provides an overview of the 2022 Clinical Practice Guideline recommendations intended for clinicians providing pain care, including those prescribing opioids for outpatients with acute, subacute, and chronic pain. You will learn how to apply the recommendations as flexible standards of care to enable patient-centered decision-making, taking into account an individual’s well-being and what may be expected to happen based on their health or medical conditions.WB4701
- Prescribing: Opioid(s)
- 2.00 ANCC
$10.00
Learn about the CDC's Opioid Guidelines, chronic opioid therapy, and tools to ensure safe and effective regimens in this CPE activity for healthcare professionals.
- Drug Diversion
- State Mandated Training
- Prescribing: Opioid(s)
- Naloxone
- 3.00 AMA PRA Category 1 Credit™
- 3.00 ANCC
$21.00
Opioid analgesic medications can bring substantial relief to patients suffering from pain. However, the inappropriate use, abuse, and diversion of prescription drugs in America, particularly prescription opioids, has increased dramatically in recent years and has been identified as a national public health epidemic, with West Virginia among the states with the largest opioid misuse and diversion problem. A set of clinical tools, guidelines, and recommendations are now available for prescribers who treat pain patients with opioids.